myrtle beach semaglutide & tirzepatide Find the Best Medical Weight Loss Clinics Programs Near You Semaglutide vs Tirzepatide in Grapevine

Family Soapmakers Since 1858

In patients with type 2 diabetes and high cardiovascularrisk, clinical trials have shown that GLP-1 receptor agonistsreduce the incidence of major adverse cardiovascular events.The effect of tirzepatide a dual incretin agonist of theGLP-1 and GIP receptors on cardiovascular outcomes isuncertain. In theSURPASS-CVOTtrial, patients40 years of age or older with type 2 diabetes, a BMIof at least 25, and atherosclerotic cardiovascular disease wererandomly assigned to receive a weekly subcutaneous injectionof tirzepatide (up to 15 mg) or dulaglutide (1.5 mg), a GLP-1receptor agonist that has been shown to reduce the incidenceof cardiovascular events

You can now choose between GLP-1 pills or shots for weight loss

Dive into the science behind GLP-1s, trends and demands employers are seeing for these drugs, and how you can ensure youve got the right building blocks for GLP-1 success.

One ...